Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v2-FR
Language French French
Date Updated 2020-07-13 2020-06-29
Drug Identification Number 02187086 02187086
Brand name BREVICON 0.5/35 TABLETS (21-DAY PACK) BREVICON 0.5/35 TABLETS (21-DAY PACK)
Common or Proper name BREVICON 21 BREVICON 21
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients ETHINYL ESTRADIOL NORETHINDRONE ETHINYL ESTRADIOL NORETHINDRONE
Strength(s) 0.035MG 0.5MG 0.035MG 0.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 21's 21's
ATC code G03AA G03AA
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-06-29 2020-06-29
Estimated end date 2020-11-06 2020-10-09
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments Limited inventory available and on preventative allocation. Limited inventory available and on preventative allocation.
Health Canada comments